0,825  0,002  Melanin inhibitor
0,811  0,012  Transcription factor NF kappa B inhibitor
0,738  0,004  Skin whitener
0,745  0,024  Apoptosis agonist
0,611  0,010  Antioxidant
0,637  0,044  Antiinflammatory
0,582  0,014  Chemopreventive
0,539  0,015  Antineoplastic (brain cancer)
0,528  0,033  Antibacterial
0,538  0,047  Caspase 9 stimulant
0,478  0,036  Prostate cancer treatment
0,453  0,021  Free radical scavenger
0,450  0,026  Lipoxygenase inhibitor
0,474  0,060  Antineoplastic (breast cancer)
0,423  0,013  Abortion inducer
0,438  0,030  Antineoplastic (pancreatic cancer)
0,426  0,028  NOS2 expression inhibitor
0,424  0,031  ICAM1 expression inhibitor
0,452  0,060  TNF expression inhibitor
0,414  0,024  Nitric oxide antagonist
0,421  0,040  Antihypercholesterolemic
0,402  0,024  Antiparasitic
0,415  0,037  Antineoplastic (melanoma)
0,409  0,031  Sensitization
0,407  0,034  Antineoplastic (glioma)
0,403  0,039  AR expression inhibitor
0,394  0,031  Antiprotozoal (Leishmania)
0,402  0,044  Caspase 3 stimulant
0,416  0,061  Antineoplastic (lung cancer)
0,372  0,020  Antihelmintic
0,435  0,101  Alpha-glucosidase inhibitor
0,360  0,037  Proliferative diseases treatment
0,380  0,062  Vasodilator, peripheral
0,403  0,089  Cyclophilin D inhibitor
0,403  0,089  Antidiabetic
0,368  0,055  Antifungal
0,340  0,032  Antiulcerative
0,340  0,038  Antineoplastic (glioblastoma multiforme)
0,373  0,072  Antileukemic
0,299  0,005  AMP-activated protein kinase stimulant
0,350  0,057  Antineoplastic (ovarian cancer)
0,331  0,049  UGT2B4 substrate
0,323  0,042  Antiglaucomic
0,358  0,082  Immunosuppressant
0,329  0,062  NOS3 expression inhibitor
0,275  0,014  Cholesterol synthesis inhibitor
0,306  0,046  Vasodilator
0,308  0,049  Cardiovascular analeptic
0,326  0,068  CYP2D6 substrate
0,281  0,024  Neurotrophic factor enhancer
0,263  0,017  UGT2B9 substrate
0,303  0,060  UGT1A9 substrate
0,338  0,098  Antiprotozoal
0,311  0,073  12-Lipoxygenase inhibitor
0,265  0,027  Antiacne
0,250  0,014  Antineoplastic antibiotic
0,272  0,038  Hepatoprotectant
0,272  0,040  UGT1A1 substrate
0,268  0,037  VCAM1 expression inhibitor
0,251  0,030  Protein-tyrosine phosphatase inhibitor
0,282  0,064  Antineoplastic (non-small cell lung cancer)
0,271  0,053  UGT1A6 substrate
0,324  0,108  CYP2C19 inhibitor
0,280  0,065  Chemoprotective
0,240  0,033  Antineoplastic (squamous cell carcinoma)
0,272  0,066  Antineoplastic (cervical cancer)
0,221  0,016  Farnesoid X receptor antagonist
0,285  0,081  CTGF expression inhibitor
0,273  0,069  Antiprotozoal (Trypanosoma)
0,212  0,008  Papain-like protease (SARS coronavirus) inhibitor
0,224  0,023  Protein-tyrosine phosphatase 1B inhibitor
0,319  0,119  15-Lipoxygenase inhibitor
0,294  0,095  Cholesterol antagonist
0,275  0,078  Radioprotector
0,274  0,079  CYP2C19 substrate
0,199  0,005  Cathepsin L2 inhibitor
0,328  0,134  Calcium channel L-type activator
0,210  0,018  Microtubule formation inhibitor
0,243  0,051  UDP-glucuronosyltransferase substrate
0,235  0,045  UGT1A4 substrate
0,213  0,037  Interferon gamma antagonist
0,212  0,037  Lipid peroxidase inhibitor
0,221  0,048  Sepsis treatment
0,210  0,039  UGT2B15 substrate
0,200  0,028  DNA polymerase I inhibitor
0,202  0,031  Antifungal enhancer
0,286  0,116  Ulceration
0,184  0,014  TRPA1 agonist
0,233  0,064  Antihypertriglyceridemic
0,256  0,087  Antiosteoporotic
0,273  0,106  Apoptosis antagonist
0,259  0,092  Hypoxia-inducible factor 1 alpha inhibitor
0,198  0,034  Monophenol monooxygenase inhibitor
0,203  0,040  NOS3 expression enhancer
0,283  0,120  CYP2C9 substrate
0,182  0,028  Antihemorrhagic
0,256  0,102  Analeptic
0,205  0,052  Dual specificity phosphatase inhibitor
0,271  0,120  Antiprotozoal (Plasmodium)
0,189  0,042  Catenin beta inhibitor
0,257  0,109  Bone diseases treatment
0,204  0,060  UGT2B7 substrate
0,222  0,080  Antihypotensive
0,275  0,135  Antiobesity
0,244  0,106  Antineoplastic (colorectal cancer)
0,148  0,010  Lipase inhibitor
0,185  0,048  Arachidonic acid antagonist
0,192  0,055  UGT1A3 substrate
0,237  0,101  Antineoplastic (colon cancer)
0,148  0,013  CDC25A inhibitor
0,217  0,082  Antineoplastic (lymphoma)
0,201  0,067  CYP2B6 inhibitor
0,167  0,040  Antifungal (Cryptococcus)
0,147  0,022  Electron transport complex I inhibitor
0,233  0,110  Respiratory analeptic
0,176  0,060  UGT2B10 substrate
0,126  0,011  Protein kinase C eta inhibitor
0,199  0,086  Antineoplastic enhancer
0,243  0,132  Antithrombotic
0,213  0,104  Superoxide dismutase inhibitor
0,172  0,064  Prostate disorders treatment
0,181  0,073  LDLR expression enhancer
0,215  0,108  Spasmolytic
0,123  0,017  Bile acid receptor antagonist
0,122  0,017  Aromatase inhibitor
0,225  0,122  Antihypoxic
0,167  0,068  Antimutagenic
0,196  0,097  Antiviral (HIV)
0,203  0,108  Antineoplastic (renal cancer)
0,151  0,056  Cyclooxygenase 1 inhibitor
0,159  0,066  Antiviral (Influenza A)
0,213  0,120  Cardioprotectant
0,179  0,087  Cytotoxic
0,181  0,094  Pneumotoxic
0,131  0,044  Choleretic
0,212  0,126  Streptokinase A inhibitor
0,132  0,048  Alcohol dehydrogenase substrate
0,127  0,044  Estrogen antagonist
0,170  0,089  P-glycoprotein inhibitor
0,117  0,036  Estrogen receptor beta antagonist
0,142  0,066  Neurotrophic factor
0,132  0,058  Coagulant
0,237  0,163  Calcium channel activator
0,214  0,140  Hepatic disorders treatment
0,084  0,012  5-Alpha-reductase inhibitor
0,102  0,030  Na+ K+ transporting ATPase inhibitor
0,096  0,024  Glycine receptor agonist
0,120  0,048  UGT2B1 substrate
0,139  0,070  Amylase inhibitor
0,143  0,074  Antineoplastic (carcinoma)
0,098  0,035  Antibiotic
0,090  0,027  HIV-1 integrase (Strand Transfer) inhibitor
0,163  0,101  Non-steroidal antiinflammatory agent
0,117  0,059  Aldehyde dehydrogenase substrate
0,091  0,034  Ca(v)3.1 blocker
0,102  0,044  Actinic keratosis treatment
0,151  0,095  Dual specificity phosphatase 3 inhibitor
0,131  0,076  Contraceptive
0,105  0,051  UGT2B11 substrate
0,116  0,063  Photosensitizer
0,127  0,074  Tubulin antagonist
0,072  0,019  Postcoital contraceptive
0,216  0,166  Sodium/bile acid cotransporter inhibitor
0,132  0,082  Protein kinase stimulant
0,176  0,126  Cytostatic
0,184  0,136  Lipoprotein disorders treatment
0,107  0,059  5-Lipoxygenase inhibitor
0,066  0,019  Glucose-6-phosphate translocase inhibitor
0,099  0,053  Protein kinase C delta inhibitor
0,095  0,050  Ornithine decarboxylase inhibitor
0,084  0,040  SULT1A2 substrate
0,096  0,053  SULT1E1 substrate
0,139  0,098  Prostatic (benign) hyperplasia treatment
0,092  0,052  ATPase (Vacuolar H+) inhibitor
0,063  0,023  Dopamine transporter inhibitor
0,211  0,171  Interleukin 2 agonist
0,065  0,028  Estrogen agonist
0,065  0,029  Postmenopausal disorders treatment
0,117  0,081  Acetylcholinesterase inhibitor
0,042  0,007  Protein kinase C beta I inhibitor
0,076  0,042  HIV-1 integrase inhibitor
0,209  0,175  GST M1-1 substrate
0,061  0,028  Pregnane X receptor antagonist
0,067  0,034  Transcription factor AP-1 inhibitor
0,080  0,048  Estrogen receptor alpha antagonist
0,085  0,053  Inducible nitric-oxide synthase inhibitor
0,174  0,142  Hypoglycemic
0,119  0,091  Vanilloid 1 agonist
0,099  0,072  Beta glucuronidase inhibitor
0,096  0,069  Anabolic
0,085  0,059  Androgen antagonist
0,132  0,107  Ca2+-transporting ATPase inhibitor
0,125  0,099  SULT1A3 substrate
0,205  0,180  CYP3A4 substrate
0,044  0,019  Estrogen receptor alpha agonist
0,066  0,041  HIV-1 integrase (3'-Processing) inhibitor
0,037  0,014  Protein kinase C beta II inhibitor
0,025  0,003  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,124  0,103  Genotoxic
0,142  0,124  Antiviral (Influenza)
0,217  0,202  Antineoplastic (small cell lung cancer)
0,122  0,109  Antiviral (Herpes)
0,021  0,010  Progesterone receptor B antagonist
0,072  0,063  Narcotic antagonist
0,112  0,104  Hair growth stimulant
0,060  0,054  Transcription factor RelA inhibitor
0,082  0,077  Breast cancer-resistant protein inhibitor

